GBR 500, a monoclonal VLA-2 antibody inhibits tumor and metastasis growth but not extravasation in a prostate cancer animal model

被引：1
|
作者：
Attinger, Antoine [1 ]
Hou, Sam [1 ]
Pesenti, Enrico A. [2 ]
Mancini, Laura [2 ]
Mottl, Harald [1 ]
机构：
[1] Glenmark Pharmaceut, La Chaux De Fonds, Switzerland
[2] Nerviano Med Sci, Nerviano, Italy
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-LB-294
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-294
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Neutralizing Monoclonal Antibody to Periostin Inhibits Ovarian Tumor Growth and Metastasis
    Zhu, Min
    Saxton, Romaine E.
    Ramos, Lillian
    Chang, David D.
    Karlan, Beth Y.
    Gasson, Judith C.
    Slamon, Dennis J.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (08) : 1500 - 1508
  • [2] Monoclonal antibody against prostate stem cell antigen (PSCA) inhibits prostate cancer growth and metastasis through a direct effect of tumor cells
    Gu, ZN
    Yamashiro, J
    Kono, E
    Reiter, R
    JOURNAL OF UROLOGY, 2003, 169 (04): : 90 - 90
  • [3] Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
    Hiroshi Tanaka
    Evelyn Kono
    Chau P Tran
    Hideyo Miyazaki
    Joyce Yamashiro
    Tatsuya Shimomura
    Ladan Fazli
    Robert Wada
    Jiaoti Huang
    Robert L Vessella
    Jaibin An
    Steven Horvath
    Martin Gleave
    Matthew B Rettig
    Zev A Wainberg
    Robert E Reiter
    Nature Medicine, 2010, 16 : 1414 - 1420
  • [4] Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance
    Tanaka, Hiroshi
    Kono, Evelyn
    Tran, Chau P.
    Miyazaki, Hideyo
    Yamashiro, Joyce
    Shimomura, Tatsuya
    Fazli, Ladan
    Wada, Robert
    Huang, Jiaoti
    Vessella, Robert L.
    An, Jaibin
    Horvath, Steven
    Gleave, Martin
    Rettig, Matthew B.
    Wainberg, Zev A.
    Reiter, Robert E.
    NATURE MEDICINE, 2010, 16 (12) : 1414 - U96
  • [5] Targeting CUB domain-containing protein 1 with a monoclonal antibody inhibits metastasis in a prostate cancer model
    Siva, Amara C.
    Wild, Martha A.
    Kirkland, Richard E.
    Nolan, Mary Jean
    Lin, Bing
    Maruyama, Toshiaki
    Yantiri-Wernimont, Ferda
    Frederickson, Shana
    Bowdish, Katherine S.
    Xin, Hong
    CANCER RESEARCH, 2008, 68 (10) : 3759 - 3766
  • [6] Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis
    Cher, ML
    Biliran, HR
    Bhagat, S
    Meng, YH
    Che, MX
    Lockett, J
    Abrams, J
    Fridman, R
    Zachareas, M
    Sheng, SJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (13) : 7847 - 7852
  • [7] Regulated Expression of CCL21 in the Prostate Tumor Microenvironment Inhibits Tumor Growth and Metastasis in an Orthotopic Model of Prostate Cancer
    Yousefieh, Nazita
    Hahto, Suzanne M.
    Stephens, Amber L.
    Ciavarra, Richard P.
    CANCER MICROENVIRONMENT, 2009, 2 (01) : 59 - 67
  • [8] Monoclonal Antibody to Transforming Growth Factor β Inhibits Tumor Burden and Osteolysis in a Pre-clinical Model of Bone Metastasis
    Biswas, S.
    Wilburn, C.
    Munoz, S. A.
    Sterling, J. A.
    Lonning, S.
    Mundy, G. R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S170 - S170
  • [9] Monoclonal antibody to human esophageal cancer endothelium inhibits angiogenesis and tumor growth
    Zhang, Yushan
    Ran, Yuliang
    Yu, Long
    Hu, Hai
    Zhou, Zhuan
    Sun, Lixin
    Lou, Jinning
    Yang, Zhihua
    ANTICANCER RESEARCH, 2006, 26 (4B) : 2963 - 2970
  • [10] The dialyzable leukocyte extract Transferon™ inhibits tumor growth and brain metastasis in a murine model of prostate cancer
    Hernandez-Esquivel, Miguel A.
    Perez-Torres, Armando
    Romero-Romero, Laura
    Reyes-Matute, Alonso
    Loaiza, Brenda
    Mellado-Sanchez, Gabriela
    Pavon, Lenin
    Medina-Rivero, Emilio
    Pestell, Richard G.
    Perez-Tapia, Sonia M.
    Velasco-Velazquez, Marco A.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 101 : 938 - 944
12345